EBS

Emergent Biosolutions Stock Price

134.0484
11.42 (9.31%)
Upgrade to Real-Time
Regular Market
134.0484
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
11.42 9.31% 134.0484 128.20 136.39 129.18 122.63 13:19:32
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
13,793 984,693 $ 131.88 $ 129,858,250 1,098,557 39.11 - 136.39
Last Trade Time Type Quantity Stock Price Currency
13:19:14 20 $ 133.9809 USD

Emergent Biosolutions Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.03B 52.43M 37.42M $ 1.11B $ 99.31M 1.03 74.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.78M $ - 0.00% - -

more financials information »

Emergent Biosolutions News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EBS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week94.00136.3992.33113.371,134,23640.0542.6%
1 Month91.20136.3986.3096.791,364,47842.8546.98%
3 Months82.40136.3964.5087.87913,05751.6562.68%
6 Months59.82136.3946.3778.13708,43374.23124.09%
1 Year44.11136.3939.1169.47534,67589.94203.9%
3 Years35.15136.3932.4859.54404,08698.90281.36%
5 Years33.18136.3924.4749.21394,730100.87304.0%

Emergent Biosolutions Description

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.